No definition available.
Mental and behavioural disorders due to use of other stimulants, including caffeine
DOID EFO Endpoint Browser PheWeb
F5_STIMUL
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1054 |
4. Check minimum number of eventsNone |
1054 |
5. Include endpointsNone |
1054 |
6. Filter based on genotype QC (FinnGen only) |
987 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Mental and behavioural disorders due to use of other stimulants, including caffeine based on the number of shared cases.
Similar with more cases:
- Substance use, excluding alcohol
- Substance abuse
- Substance abuse
- Mental and behavioural disorders due to psychoactive substance use
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 14032 | 4086 | 9842 |
Only index persons | 12674 | 3871 | 8803 |
Unadjusted period prevalence (%) | |||
Whole population | 0.23 | 0.12 | 0.27 |
Only index persons | 0.28 | 0.14 | 0.34 |
Median age at first event (years) | |||
Whole population | 26.36 | 24.29 | 27.19 |
Only index persons | 26.26 | 24.21 | 27.15 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 987 | 395 | 592 |
Unadjusted period prevalence (%) | 0.24 | 0.16 | 0.30 |
Median age at first event (years) | 26.97 | 25.56 | 27.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint F5_STIMUL and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
F5_STIMUL | 9.742 [6.72, 14.13] | < 0.001 |
Birth year | 0.995 [0.99, 1.0] | 0.242 |
During the follow-up period (1.1.1998 — 31.12.2019), 297 out of 3106 females with F5_STIMUL died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
F5_STIMUL | 9.704 [8.62, 10.92] | < 0.001 |
Birth year | 0.99 [0.98, 1.0] | 0.024 |
During the follow-up period (1.1.1998 — 31.12.2019), 1150 out of 6957 males with F5_STIMUL died.
Mortality risk
Mortality risk for people of age
years, who have F5_STIMUL.N-year risk | Females | Males |
---|---|---|
1 | 0.892% | 1.823% |
5 | 6.188% | 10.148% |
10 | 14.644% | 25.694% |
15 | 25.708% | 45.373% |
20 | 40.894% | 65.742% |
Relationships between endpoints
↥Index endpoint: F5_STIMUL – Mental and behavioural disorders due to use of other stimulants, including caffeine
GWS hits: -